Experts at Fall Clinical Derm 2026 urge early JAK inhibitors over systemic steroids for atopic dermatitis and long-term vitiligo treatment, saying boxed-warning risks are overstated.
|Slideshows|March 14, 2019
10 Ways Health Execs Can Improve Organizational Productivity
Author(s)Tracey Walker
A successful organization is a productive one, but a lot can stand in your way. Here’s how to get around the barriers to create a more efficient working environment.
Advertisement
Advertisement
Related to this article
Art Papier, M.D., CEO of VisualDx, says darker skin tones have been underrepresented in dermatology resources for decades and explains how his company works backward from known diagnostic errors.
The 2026 American Academy of Ophthalmology Meeting got started today in New Orleans with a mix of celebration and candor about the challenges facing ophthalmology today.
How LLM decision support reshapes dermatology care, helping non-specialists diagnose while navigating trust gaps, ambiguity, and hallucination risks at Fall Clinical Derm.
Real-world data at the 2026 Fall Clinical Dermatology Conference show dupilumab in children with atopic dermatitis cuts new allergies and asthma risk versus steroids.
Sagimet CEO David Happel shares insights on denifanstat, highlighting strong acne response, tolerability and optimism for a denifanstat U.S. trial.
Sagimet CEO David Happel says oral denifanstat could sharply cut antibiotic use in acne and be used before patients ever need isotretinoin.
Sagimet Biosciences’ denifanstat oral acne pill shows rapid, sustained lesion cuts and higher clear-skin rates in phase 3, offering an antibiotic-sparing option.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
AI could utterly transform healthcare. But reduce its cost? Perhaps not so much.
2
A conversation about the cycle of ADHD and sleep problems in children, with Alison Pritchard, Ph.D.
3
PhRMA sues Trump administration over Medicare Part B drug pricing model
4
8 dermatology developments from 2026 that experts say matter most | 2026 Fall Clinical Derm
5